


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 6 Aug 2012
Astellas to Close Urogenix, North Carolina-based Urology Research Facility
Astellas to Close Urogenix, North Carolina-based Urology Research Facility
HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
HSMN NewsFeed - 30 Jul 2012
Biovest Advances Process Seeking European Marketing Approval for BiovaxID(TM) Personalized Lymphoma Vaccine
Biovest Advances Process Seeking European Marketing Approval for BiovaxID(TM) Personalized Lymphoma Vaccine
HSMN NewsFeed - 27 Jul 2012
Roche and AREVA Med Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy
Roche and AREVA Med Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy
HSMN NewsFeed - 26 Jul 2012
Durata Therapeutics Adds Independent Director Lisa M. Giles to the Company’s Board
Durata Therapeutics Adds Independent Director Lisa M. Giles to the Company’s Board
HSMN NewsFeed - 26 Jul 2012
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
HSMN NewsFeed - 25 Jul 2012
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
HSMN NewsFeed - 24 Jul 2012
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
HSMN NewsFeed - 24 Jul 2012
Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
HSMN NewsFeed - 20 Jul 2012
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
HSMN NewsFeed - 20 Jul 2012
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
HSMN NewsFeed - 20 Jul 2012
First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP
First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP
HSMN NewsFeed - 19 Jul 2012
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
HSMN NewsFeed - 12 Jul 2012
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
HSMN NewsFeed - 10 Jul 2012
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
HSMN NewsFeed - 9 Jul 2012
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
HSMN NewsFeed - 9 Jul 2012
Affymax Promotes Michael Holfinger, Ph.D., to Vice President, Manufacturing and CMC Development
Affymax Promotes Michael Holfinger, Ph.D., to Vice President, Manufacturing and CMC Development
HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
HSMN NewsFeed - 27 Jun 2012
BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
HSMN NewsFeed - 23 Jun 2012
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
HSMN NewsFeed - 22 Jun 2012
Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
HSMN NewsFeed - 21 Jun 2012
Oncothyreon Announces Promotion of Scott Peterson, Ph.D., to Chief Scientific Officer
Oncothyreon Announces Promotion of Scott Peterson, Ph.D., to Chief Scientific Officer
HSMN NewsFeed - 21 Jun 2012
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
HSMN NewsFeed - 21 Jun 2012
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
HSMN NewsFeed - 20 Jun 2012
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
HSMN NewsFeed - 19 Jun 2012
AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
HSMN NewsFeed - 18 Jun 2012
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
HSMN NewsFeed - 13 Jun 2012
Stratatech’s StrataGraft(R) Skin Substitute Granted FDA Orphan Drug Designation
Stratatech’s StrataGraft(R) Skin Substitute Granted FDA Orphan Drug Designation
HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
